Published in J Virol on November 01, 1993
Proteomic analysis of urine exosomes reveals renal tubule response to leptospiral colonization in experimentally infected rats. PLoS Negl Trop Dis (2015) 1.92
Envelopment of human cytomegalovirus occurs by budding into Golgi-derived vacuole compartments positive for gB, Rab 3, trans-golgi network 46, and mannosidase II. J Virol (2003) 1.80
Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B. J Virol (1998) 1.56
Host cellular annexin II is associated with cytomegalovirus particles isolated from cultured human fibroblasts. J Virol (1995) 1.37
Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation. J Virol (2001) 1.35
Determinants essential for the transmissible gastroenteritis virus-receptor interaction reside within a domain of aminopeptidase-N that is distinct from the enzymatic site. J Virol (1994) 1.25
Epidermal growth factor receptor is not required for human cytomegalovirus entry or signaling. J Virol (2007) 1.21
Human coronavirus 229E binds to CD13 in rafts and enters the cell through caveolae. J Virol (2004) 1.18
Cell surface proteoglycans are not essential for infection by pseudorabies virus. J Virol (1995) 1.17
Human cytomegalovirus entry into dendritic cells occurs via a macropinocytosis-like pathway in a pH-independent and cholesterol-dependent manner. PLoS One (2012) 1.14
An endoplasmic reticulum protein, p180, is highly expressed in human cytomegalovirus-permissive cells and interacts with the tegument protein encoded by UL48. J Virol (2002) 1.14
The cytomegalovirus-encoded chemokine receptor US28 can enhance cell-cell fusion mediated by different viral proteins. J Virol (1998) 1.04
Direct interaction between human cytomegalovirus glycoprotein B and cellular annexin II. J Virol (1997) 1.04
Human cytomegalovirus induction of a unique signalsome during viral entry into monocytes mediates distinct functional changes: a strategy for viral dissemination. J Leukoc Biol (2012) 0.94
Inhibitory effect of antisense aminopeptidase N (APN/CD13) cDNA transfection on the invasive potential of osteosarcoma cells. Clin Exp Metastasis (2003) 0.90
Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology. Virulence (2012) 0.84
Involvement of aminopeptidase N (CD13) in infection of human neural cells by human coronavirus 229E. J Virol (1998) 0.83
Molecular mechanism of pathogenesis of dengue virus: Entry and fusion with target cell. Indian J Clin Biochem (2005) 0.81
The pro-inflammatory cytokine 14-3-3ε is a ligand of CD13 in cartilage. J Cell Sci (2015) 0.76
Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031. Bone Marrow Transplant (2010) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
The major human rhinovirus receptor is ICAM-1. Cell (1989) 7.81
Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J Virol (1989) 7.11
Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A (1984) 6.62
Zinc coordination, function, and structure of zinc enzymes and other proteins. Biochemistry (1990) 6.41
Plaque assay of cytomegalovirus strains of human origin. Proc Soc Exp Biol Med (1970) 5.90
Human aminopeptidase N is a receptor for human coronavirus 229E. Nature (1992) 3.91
Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature (1992) 3.89
Studies in subviral components of Semliki Forest virus. Ann Med Exp Biol Fenn (1969) 3.59
Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment. Ann Intern Med (1988) 3.49
Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology (1993) 3.42
Insertion and deletion mutagenesis of the human cytomegalovirus genome. Proc Natl Acad Sci U S A (1987) 3.04
Anchoring and biosynthesis of stalked brush border membrane proteins: glycosidases and peptidases of enterocytes and renal tubuli. Annu Rev Cell Biol (1986) 2.49
Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Invest (1989) 2.23
Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site? Cell (1983) 2.11
A human cytomegalovirus glycoprotein complex designated gC-II is a major heparin-binding component of the envelope. J Virol (1992) 1.88
Restoration of specific myxovirus receptors to asialoerythrocytes by incorporation of sialic acid with pure sialyltransferases. J Biol Chem (1979) 1.53
Expression of a human cytomegalovirus receptor correlates with infectibility of cells. J Virol (1991) 1.48
Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J Virol (1993) 1.48
The recognition event between virus and host cell receptor: a target for antiviral agents. J Gen Virol (1990) 1.47
Beta 2 microglobulin enhances the infectivity of cytomegalovirus and when bound to the virus enables class I HLA molecules to be used as a virus receptor. J Gen Virol (1987) 1.44
Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes. J Med Chem (1984) 1.44
Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation (1977) 1.40
Anti-idiotype antibodies that mimic gp86 of human cytomegalovirus inhibit viral fusion but not attachment. J Virol (1991) 1.36
Identification of cell surface receptors for the 86-kilodalton glycoprotein of human cytomegalovirus. Proc Natl Acad Sci U S A (1989) 1.34
Rapid detection of cytomegalovirus in cell culture by indirect immunoperoxidase staining with monoclonal antibody to an early nuclear antigen. J Clin Microbiol (1985) 1.28
The human cytomegalovirus receptor on fibroblasts is a 30-kilodalton membrane protein. J Virol (1990) 1.27
Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells. Blood (1990) 1.26
Identification of a putative cell receptor for human cytomegalovirus. Virology (1990) 1.21
Molecular biology and immunology of cytomegalovirus. Biochem J (1987) 1.19
The slow, tight binding of bestatin and amastatin to aminopeptidases. J Biol Chem (1985) 1.06
Production of actinonin, an inhibitor of aminopeptidase M, by actinomycetes. J Antibiot (Tokyo) (1985) 1.04
Human cytomegalovirus binding to fibroblasts is receptor mediated. J Virol (1989) 1.03
Further characterization of human myeloid antigens (gp160,95; gp150; gp67): investigation of epitopic heterogeneity and non-haemopoietic distribution using panels of monoclonal antibodies belonging to CD-11b, CD-13 and CD-33. Br J Haematol (1988) 1.02
Deletion of the zinc-binding motif of CD13/aminopeptidase N molecules results in loss of epitopes that mediate binding of inhibitory antibodies. Blood (1992) 0.97
Viral infections associated with bone marrow transplantation. Hematol Oncol Clin North Am (1990) 0.88
STUDIES OF UREA EXCRETION. III: The Influence of Body Size on Urea Output. J Clin Invest (1928) 45.56
STUDIES OF UREA EXCRETION: VI. Comparison of the Blood Urea Clearance with Certain Other Measures of Renal Function. J Clin Invest (1930) 7.46
Ribozymes as potential anti-HIV-1 therapeutic agents. Science (1990) 4.49
Growth inhibition by acycloguanosine of herpesviruses isolated from human infections. Antimicrob Agents Chemother (1979) 3.61
A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group. N Engl J Med (1991) 3.05
Antibody to varicella-zoster virus-induced membrane antigen: immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells. J Infect Dis (1977) 2.65
Studies on antigen-binding cells. I. The origin of reactive cells. Cell Immunol (1970) 2.53
Transplantation of porcine fetal pancreas to diabetic patients. Lancet (1994) 2.52
Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J Med Virol (1994) 2.50
"Spontaneous" B cell activation due to loss of normal mouse serum suppressor. Eur J Immunol (1972) 2.38
Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir Dis (1983) 2.38
Membrane fusion of Semliki Forest virus in a model system: correlation between fusion kinetics and structural changes in the envelope glycoprotein. EMBO J (1993) 2.36
Membrane fusion process of Semliki Forest virus. II: Cleavage-dependent reorganization of the spike protein complex controls virus entry. J Cell Biol (1992) 2.26
Phase-coupling of theta-gamma EEG rhythms during short-term memory processing. Int J Psychophysiol (2002) 2.09
Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med (1983) 2.03
Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med (1983) 1.90
Long-term follow-up of patients with untreated scoliosis. A study of mortality, causes of death, and symptoms. Spine (Phila Pa 1976) (1992) 1.88
The risk of lung cancer and mesothelioma after cessation of asbestos exposure: a prospective cohort study of shipyard workers. Eur Respir J (1992) 1.87
Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture. Transplantation (1997) 1.84
Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting. Circulation (2005) 1.83
Polyclonal antibody secretion in human lymphocytes induced by killed staphylococcal bacteria and by lipopolysaccharide. Scand J Immunol (1977) 1.82
Direct detection of HIV-1 RNA from AIDS and ARC patient samples. DNA (1988) 1.79
Epidemiology of scapular fractures. Incidence and classification of 338 fractures. Acta Orthop Scand (1995) 1.76
Elevated aggrecanase activity in a rat model of joint injury is attenuated by an aggrecanase specific inhibitor. Osteoarthritis Cartilage (2010) 1.75
Expression of small, therapeutic RNAs in human cell nuclei. Gene Ther (1997) 1.71
Xylene-free method for histological preparation: a multicentre evaluation. Lab Invest (2001) 1.70
Randomized clinical trial of laparoscopic versus open fundoplication: blind evaluation of recovery and discharge period. Br J Surg (2000) 1.64
Reducing delirium in elderly patients with hip fracture: a multi-factorial intervention study. Acta Anaesthesiol Scand (2010) 1.61
Specificity of the blastogenic response of human mononuclear cells to herpesvirus antigens. Infect Immun (1978) 1.60
Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining. J Immunol Methods (1993) 1.60
The aetiology and epidemiology of clavicular fractures. A prospective study during a two-year period in Uppsala, Sweden. Injury (2000) 1.59
HLA and rheumatoid arthritis. A study of five families. Tissue Antigens (1981) 1.58
Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol in asthmatics. Am Rev Respir Dis (1977) 1.58
Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand? Blood (1994) 1.56
HL-A antigens in sarcoidosis. Tissue Antigens (1973) 1.55
Plaque-formation by non-immune and x-irradiated lymphoid cells on monolayers of mouse embryo cells. Nature (1965) 1.55
The imprint of the extragalactic background light in the gamma-ray spectra of blazars. Science (2012) 1.53
Arthroscopic lavage reduced the recurrence rate following primary anterior shoulder dislocation. A randomised multicentre study with 1-year follow-up. Knee Surg Sports Traumatol Arthrosc (1999) 1.52
Insect performance on experimentally stressed woody plants: a meta-analysis. Annu Rev Entomol (1998) 1.51
Health-related quality of life in COPD: why both disease-specific and generic measures should be used. Eur Respir J (2001) 1.50
Clinical consequences of inadequate inhalation technique in asthma therapy. Eur J Respir Dis (1987) 1.48
Spleen cells from animals tolerant to a thymus-dependent antigen can be activated by lipopolysaccharide to synthesize antibodies against the tolerogen. J Exp Med (1976) 1.48
Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J Virol (1993) 1.48
Listeria monocytogenes causing hospital-acquired enterocolitis and meningitis in newborn infants. Br Med J (1978) 1.47
Role of polyclonal activation in specific immune responses. Relevance for findings of antibody activity in various diseases. Scand J Immunol (1980) 1.46
Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis. J Infect Dis (1979) 1.46
Bronchial brush biopsies for studies of epithelial inflammation in stable asthma and nonobstructive chronic bronchitis. Eur Respir J (1996) 1.45
Intrapleural streptokinase in the treatment of haemothorax and empyema. Scand J Thorac Cardiovasc Surg (1977) 1.43
Assembly and entry mechanisms of Semliki Forest virus. Arch Virol Suppl (1994) 1.42
Value of air trapping in detection of small airways disease in smokers. Acta Radiol (2003) 1.41
Similar quality of life after heart valve replacement with mechanical or bioprosthetic valves. J Heart Valve Dis (1995) 1.40
Airborne transmission of chickenpox in a hospital. N Engl J Med (1980) 1.39
Functional status and well being in chronic obstructive pulmonary disease with regard to clinical parameters and smoking: a descriptive and comparative study. Thorax (1996) 1.38
Fermi observations of high-energy gamma-ray emission from GRB 080916C. Science (2009) 1.37
Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci U S A (1989) 1.36
Antigen binding cells in tolerant animals. Nature (1970) 1.35
Spike protein oligomerization control of Semliki Forest virus fusion. J Virol (1990) 1.34
In vitro assay of cell-mediated immunity: the inhibition of migration of sensitized human lymphocytes by HL-A antigens. Clin Exp Immunol (1970) 1.32
Lung function in adult idiopathic scoliosis: a 20 year follow up. Thorax (1991) 1.32
Scandiatransplant: preliminary report of a kidney exchange program. Transplant Proc (1971) 1.32
Studies on antigen-binding cells. II. Relationship to antigen-sensitive cells. Cell Immunol (1970) 1.31
Cloning and physical mapping of a gene fragment coding for a 64-kilodalton major late antigen of human cytomegalovirus. Proc Natl Acad Sci U S A (1984) 1.30
Reliability and validity of a Swedish version of the St George's Respiratory Questionnaire. Eur Respir J (1998) 1.30
Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments. Osteoarthritis Cartilage (2005) 1.27
B-cell mitogenic effects on human lymphocytes of rabbit anti-human beta 2-microglobulin. Scand J Immunol (1975) 1.27
Tremor caused by sympathomimetics is mediated by beta2-adrenoreceptors. Scand J Respir Dis (1977) 1.27
Preoperative gastric emptying. Effects of anxiety and oral carbohydrate administration. Ann Surg (1995) 1.26
The oligomerization reaction of the Semliki Forest virus membrane protein subunits. J Cell Biol (1995) 1.26
Quantitation of C-reactive protein levels and erythrocyte sedimentation rate after spinal surgery. Spine (Phila Pa 1976) (1992) 1.26
No effect of low-intensity ultrasound on healing time of intramedullary fixed tibial fractures. J Orthop Trauma (1999) 1.25
Lack of bronchial beta adrenoceptor resistance in asthmatics during long-term treatment with terbutaline. J Allergy Clin Immunol (1977) 1.24
Biomechanical comparison of five different atlantoaxial posterior fixation techniques. Spine (Phila Pa 1976) (2000) 1.24
Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella. J Infect Dis (1983) 1.24
Histological typing of lung cancer. Application of the World Health Organization classification to 479 cases. Acta Pathol Microbiol Scand A (1976) 1.24
The role of adherent cells in B and T lymphocyte activation. Immunol Rev (1978) 1.23
Prolonged human cytomegalovirus viremia following bone marrow transplantation. Transplantation (1984) 1.23
Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years. Clin Exp Immunol (2011) 1.23
Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion (1998) 1.21
HLA-DR-DQ haplotypes defined by restriction fragment analysis. Correlation to serology. Hum Immunol (1987) 1.20
Impacts of elevated terrestrial nutrient loads and temperature on pelagic food-web efficiency and fish production. Glob Chang Biol (2013) 1.19
Complete heart block--another HLA B27 associated disease manifestation. Tissue Antigens (1983) 1.16
Electrical stimulation versus coronary artery bypass surgery in severe angina pectoris: the ESBY study. Circulation (1998) 1.16
B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukaemia. Clin Exp Immunol (1978) 1.14
Clinical aspects on 64 cases of juvenile and adult listeriosis in Sweden. Acta Med Scand (1978) 1.14
Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax (1995) 1.14
Antimicrobial susceptibilities of Listeria monocytogenes strains isolated from 1958 to 1982 in Sweden. Antimicrob Agents Chemother (1985) 1.13
Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes. Gene (1994) 1.13
Cytotoxicity by nonimmune allogeneic lymphoid cells. Specific suppression by antibody treatment of the lymphoid cells. J Exp Med (1967) 1.12
Negligible clearance of ultrafine particles retained in healthy and affected human lungs. Eur Respir J (2006) 1.12
Inhaled formoterol during one year in asthma: a comparison with salbutamol. Eur Respir J (1991) 1.12
Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J Immunol (1986) 1.11
Cumulative dose-response curves for comparison of oral bronchodilating drugs. A study of salbutamol and fenoterol. Ann Allergy (1977) 1.11
Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol (1996) 1.11
The significance of radiolucent zones surrounding pedicle screws. Definition of screw loosening in spinal instrumentation. J Bone Joint Surg Br (2004) 1.10
Induction of antibody synthesis in human B lymphocytes by different polyclonal B cell activators: evaluation by direct and indirect PFC assays. Immunol Rev (1979) 1.10
Prevalence of incidental paranasal sinuses opacification in pediatric patients: a CT study. J Comput Assist Tomogr (1987) 1.10
Epidermal growth factor stimulates tyrosine phosphorylation of specific proteins in permeabilized human fibroblasts. J Biol Chem (1985) 1.10
Long-term effects of a pulmonary rehabilitation programme in outpatients with chronic obstructive pulmonary disease: a randomized controlled study. Scand J Rehabil Med (1999) 1.09